Pathalys Pharma Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
8
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$105M
- Investors
-
12
Pathalys Pharma General Information
Description
Developer of advanced therapeutics designed to address unmet needs in the management of late-stage chronic kidney diseases. The company creates upacicalcet, which is a novel calcimimetic with the potential to improve the treatment of SHPT (secondary hyperparathyroidism) in hemodialysis patients by mimicking the action of calcium on tissues through the activation of the calcium-sensing receptor that is expressed in various human organ tissues, enabling healthcare companies to treat patients with end-stage critical kidney disease.
Contact Information
Website
www.pathalys.comCorporate Office
- 4000 Center at North Hills
- Suite 470
- Raleigh, NC 27609
- United States
Corporate Office
- 4000 Center at North Hills
- Suite 470
- Raleigh, NC 27609
- United States
Pathalys Pharma Timeline
Pathalys Pharma Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Early Stage VC (Series B) | 07-Aug-2024 | $105M | Completed | Clinical Trials - Phase 3 | ||
| 2. Early Stage VC | 13-Jan-2023 | Completed | Clinical Trials - Phase 3 | |||
| 1. Early Stage VC (Series A) | 01-Mar-2022 | $11M | $11M | Completed | Clinical Trials - General |
Pathalys Pharma Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A-2 | ||||||||
| Series A-1 | 3,090,996 | $0.000100 | $9.71 | $9.71 | 1x | $9.71 | 11.37% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Pathalys Pharma Comparisons
Industry
Financing
Details
Pathalys Pharma Competitors (1)
One of Pathalys Pharma’s competitors is Oxalo Therapeutics, a Accelerator/Incubator Backed company based in Chicago, IL.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Oxalo Therapeutics | Accelerator/Incubator Backed | Chicago, IL |
Pathalys Pharma Signals
Pathalys Pharma Investors (12)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Japan Post Bank Asset Management | PE/Buyout | Minority | ||
| JPMorgan Life Sciences Private Capital | Venture Capital | Minority | ||
| KB Investment | Venture Capital | Minority | ||
| Marshall Wace | Hedge Fund | Minority | ||
| Samsara BioCapital | Venture Capital | Minority |
Pathalys Pharma FAQs
-
When was Pathalys Pharma founded?
Pathalys Pharma was founded in 2021.
-
Where is Pathalys Pharma headquartered?
Pathalys Pharma is headquartered in Raleigh, NC.
-
What is the size of Pathalys Pharma?
Pathalys Pharma has 8 total employees.
-
What industry is Pathalys Pharma in?
Pathalys Pharma’s primary industry is Drug Discovery.
-
Is Pathalys Pharma a private or public company?
Pathalys Pharma is a Private company.
-
What is the current valuation of Pathalys Pharma?
The current valuation of Pathalys Pharma is .
-
What is Pathalys Pharma’s current revenue?
The current revenue for Pathalys Pharma is .
-
How much funding has Pathalys Pharma raised over time?
Pathalys Pharma has raised $266M.
-
Who are Pathalys Pharma’s investors?
Japan Post Bank Asset Management, JPMorgan Life Sciences Private Capital, KB Investment, Marshall Wace, and Samsara BioCapital are 5 of 12 investors who have invested in Pathalys Pharma.
-
Who are Pathalys Pharma’s competitors?
Oxalo Therapeutics is a competitor of Pathalys Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process